BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29345968)

  • 1. Mature gastric chief cells are not required for the development of metaplasia.
    Kinoshita H; Hayakawa Y; Niu Z; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Hirata Y; Wang TC; Koike K
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G583-G596. PubMed ID: 29345968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
    Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
    Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
    Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
    Radyk MD; Burclaff J; Willet SG; Mills JC
    Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.
    Hata M; Kinoshita H; Hayakawa Y; Konishi M; Tsuboi M; Oya Y; Kurokawa K; Hayata Y; Nakagawa H; Tateishi K; Fujiwara H; Hirata Y; Worthley DL; Muranishi Y; Furukawa T; Kon S; Tomita H; Wang TC; Koike K
    Gastroenterology; 2020 May; 158(6):1650-1666.e15. PubMed ID: 32032583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
    Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
    Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
    Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
    Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
    Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
    Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist.
    Goldenring JR; Nam KT; Mills JC
    Exp Cell Res; 2011 Nov; 317(19):2759-64. PubMed ID: 21907708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
    Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa.
    Caldwell B; Meyer AR; Weis JA; Engevik AC; Choi E
    Gut; 2022 Jun; 71(6):1068-1077. PubMed ID: 34497145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.
    Bockerstett KA; Lewis SA; Noto CN; Ford EL; Saenz JB; Jackson NM; Ahn TH; Mills JC; DiPaolo RJ
    Gastroenterology; 2020 Dec; 159(6):2116-2129.e4. PubMed ID: 32835664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
    Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and Differentiation of Gastric Mucous Neck and Chief Cells During Homeostasis and Injury-induced Metaplasia.
    Burclaff J; Willet SG; Sáenz JB; Mills JC
    Gastroenterology; 2020 Feb; 158(3):598-609.e5. PubMed ID: 31589873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 Governs Gastric Mucous Neck Cell Identity and Is Required for Injury-Induced Metaplasia.
    Willet SG; Thanintorn N; McNeill H; Huh SH; Ornitz DM; Huh WJ; Hoft SG; DiPaolo RJ; Mills JC
    Cell Mol Gastroenterol Hepatol; 2023; 16(3):325-339. PubMed ID: 37270061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of SPEM and its standing in the preneoplastic process.
    Weis VG; Goldenring JR
    Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.
    Lennerz JK; Kim SH; Oates EL; Huh WJ; Doherty JM; Tian X; Bredemeyer AJ; Goldenring JR; Lauwers GY; Shin YK; Mills JC
    Am J Pathol; 2010 Sep; 177(3):1514-33. PubMed ID: 20709804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
    Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
    Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
    Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
    Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
    Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
    Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.